Ensuring Supply Chain Security in a Post-Pandemic World

Recent events have given manufacturers cause to revisit their supply chains.

  • What steps can companies take to ensure supply chain security in an increasingly volatile environment?
  • Will near-shoring of the supply chain improve processes and what impact will it have on product pricing?
  • Elongated lead times are impacting supply. What can companies do to mitigate the issue and to safeguard the supply chain?

John Johnson and guests will look at an issue that has come to the fore in light of recent events such as the Covid-19 related shutdowns.


LYNNE BYERS | Global Managing Director, Pharmaceuticals and Dietary Supplements Consulting | NSF


DIPTI GULATI | Executive Vice President, Pharma and Biotech | NSF, USA
MATTHEW WINTERMAN | Global Head of Pharma E2E Supply Chain Management and CDMO | Roche
CATHERINE BLACKMAN | Vice President for Therapy Supply Chain | GSK